Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS‐induced acute lung injury

Acute inflammatory diseases are the leading causes of mortality in intensive care units. Myeloid differentiation 2 (MD‐2) is required for recognizing lipopolysaccharide (LPS) by toll‐like receptor 4 (TLR4), and represents an attractive therapeutic target for LPS‐induced inflammatory diseases. In thi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Zhang, Yali, Xu, Tingting, Wu, Beibei, Chen, Hongjin, Pan, Zheer, Huang, Yi, Mei, Liqin, Dai, Yuanrong, Liu, Xing, Shan, Xiaoou, Liang, Guang
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345657/
https://ncbi.nlm.nih.gov/pubmed/27860279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars